Yifan Pharmaceutical wins first China melatonin granules approval

Yifan Pharmaceutical's subsidiary Suzhou Yifan Pharmaceutical received acceptance from China's National Medical Products Administration for its melatonin granules application on August 5.

The 1g:2mg dosage product for children aged 6-15 with sleep difficulties represents the first generic application for melatonin granules in China. The company invested approximately 1.37 billion yuan in R&D for this project.